{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:12:51Z","timestamp":1779930771053,"version":"3.53.1"},"reference-count":235,"publisher":"Rambam Health Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10388","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:14:18Z","timestamp":1584018858000},"page":"e0006","source":"Crossref","is-referenced-by-count":13,"title":["Cannabis, One Health, and Veterinary Medicine: Cannabinoids\u2019 Role in Public Health, Food Safety, and Translational Medicine"],"prefix":"10.5041","volume":"11","author":[{"given":"Sivan","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Zadik-Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Almogi-Hazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuven","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"ref0","unstructured":"1. One Health Initiative. Mission Statement. Published 2018. Available at: http:\/\/www.onehealthinitiative. com\/mission.php (accessed November 7, 2019)."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/psp4.12262","article-title":"Model-based reverse translation between veterinary and human medicine: the One Health Initiative","volume":"7","author":"Schneider","year":"2018","unstructured":"2. Schneider B, Balbas-Martinez V, Jergens AE, Troconiz IF, Allenspach K, Mochel JP. Model-based reverse translation between veterinary and human medicine: the One Health Initiative. CPT Pharmacometrics Syst Pharmacol 2018;7:65-8.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/10773525.2018.1517234","article-title":"Occupational health and safety in cannabis production: an Australian perspective","volume":"24","author":"Davidson","year":"2018","unstructured":"3. Davidson M, Reed S, Oosthuizen J, et al. Occupational health and safety in cannabis production: an Australian perspective. Int J Occup Environ Health 2018;24:75-85.","journal-title":"Int J Occup Environ Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/15459624.2018.1432863","article-title":"Microbial hazards during harvesting and processing at an outdoor United States cannabis farm","volume":"15","author":"Green","year":"2018","unstructured":"4. Green BJ, Couch JR, Lemons AR, et al. Microbial hazards during harvesting and processing at an outdoor United States cannabis farm. J Occup Environ Hyg 2018;15:430-40.","journal-title":"J Occup Environ Hyg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/bcp.13695","article-title":"Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects","volume":"84","author":"Dryburgh","year":"2018","unstructured":"5. Dryburgh LM, Bolan NS, Grof CPL, et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol 2018; 84:2468-76.","journal-title":"Br J Clin Pharmacol"},{"key":"ref5","unstructured":"6. Denver Department of Public Health & Environment (DDPHE). Bonsai cultivation voluntarily recalls retail marijuana, retail marijuana products due to presence of yeast\/mold. Published 2019. Available at: https:\/\/marijuanaretailreport.com\/bonsai-cultivation-voluntarily-recalls-retail-marijuana-retail-marijuana-products-due-to-presence-of-yeast-mold\/ (accessed January 21, 2020)."},{"key":"ref6","unstructured":"7. World Health Organization (WHO). International Food Safety Authorities Network (INFOSAN)-monitoring for chemicals in foods monitoring for chemicals in foods summary notes; 2009. Available at: https:\/\/www.who.int\/foodsafety\/fs_management\/No_01_Chem_Mar09_en.pdf (accessed January 20, 2020)."},{"key":"ref7","unstructured":"8. International Agency for Research on Cancer (IARC) Working Group on the evaluation of carcinogenic risks to Humans. Red meat and processed meat. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 114. Lyon, France: International Agency for Research on Cancer (IARC); 2018. Available at: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Red-Meat-And-Processed-Meat-2018 (accessed January 8, 2020)."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Silva DAS, Tremblay MS, Souza MFM, Mooney M, Naghavi M, Malta DC. Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): findings from the global burden of disease study. PLoS One 2018;13:e0190943.","DOI":"10.1371\/journal.pone.0190943"},{"key":"ref9","unstructured":"10. GBD 2017 Colorectal Cancer Collaborators. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2019;4:913-33."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-7547-8-2","article-title":"Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis","volume":"8","author":"Ginsberg","year":"2010","unstructured":"11. Ginsberg GM, Lim SS, Lauer JA, Johns BP, Sepulveda CR. Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis. Cost Eff Resour Alloc 2010;8:2.","journal-title":"Cost Eff Resour Alloc"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Steiner T, Syed B. Phytogenic Feed Additives in Animal Nutrition. In: M\u00e1th\u00e9 \u00c1, ed. Medicinal and Aromatic Plants of the World: Scientific, Production, Commercial and Utilization Aspects. 1st ed. New York, NY: Springer Science+Media; 2015:403-23.","DOI":"10.1007\/978-94-017-9810-5_20"},{"key":"ref12","unstructured":"13. European Monitoring Centre for Drugs and Drug Addiction. Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. Luxembourg: Publications Office of the European Union; 2018."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bcp.13496","article-title":"Nutraceuticals: opening the debate for a regulatory framework","volume":"84","author":"Santini","year":"2018","unstructured":"14. Santini A, Cammarata SM, Capone G, et al. Nutraceuticals: opening the debate for a regulatory framework. Br J Clin Pharmacol 2018;84:659-72.","journal-title":"Br J Clin Pharmacol"},{"key":"ref14","unstructured":"15. European Monitoring Centre for Drugs and Drug Addiction. Cannabis policy: status and recent developments. Available at:"},{"key":"ref15","unstructured":"http:\/\/www.emcdda.europa.eu\/publications\/topic-overviews\/cannabis-policy\/html_en (accessed January 8, 2020)."},{"key":"ref16","unstructured":"16. US Food and Drug Administration (FDA). Dietary Supplement Products & Ingredients. Published 2017. Available at: https:\/\/www.fda.gov\/food\/dietary-supplements\/dietary-supplement-products-ingredients (accessed November 26, 2019)."},{"key":"ref17","unstructured":"17. Grand View Research Inc. Dietary Supplements Market Worth $194.63 Billion By 2025 | CAGR 7.8%. Published 2019. Available at:"},{"key":"ref18","unstructured":"https:\/\/www.grandviewresearch.com\/press-release\/global-dietary-supplements-market )accessed November 10, 2019(."},{"key":"ref19","unstructured":"18. Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 2008;29:192-200."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/can.2016.0009","article-title":"Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes","volume":"1","author":"Russo","year":"2016","unstructured":"19. Russo EB. Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis Cannabinoid Res 2016;1:154-65.","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref21","unstructured":"20. Smith SC, Wagner MS. Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 2014;35:198-201."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.15406\/mojfpt.2018.06.00188","article-title":"Nutraceutical potential of selected spices, vegetables used as animal feed, and agri-food wastes","volume":"6","author":"Baiano","year":"2018","unstructured":"21. Baiano A, Assunta Previtali M. Nutraceutical potential of selected spices, vegetables used as animal feed, and agri-food wastes. MOJ Food Processing & Technology 2018;6:362-6.","journal-title":"MOJ Food Processing & Technology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/molecules23071717","article-title":"Essential oils as feed additives-future perspectives","volume":"23","author":"Stevanovi\u0107","year":"2018","unstructured":"22. Stevanovi\u0107 ZD, Bo\u0161njak-Neum\u00fcller J, Paji\u0107-Lijakovi\u0107 I, Raj J, Vasiljevi\u0107 M. Essential oils as feed additives-future perspectives. Molecules 2018;23:1717.","journal-title":"Molecules"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"23. Kilcawley K, Faulkner H, Clarke H, O'Sullivan M, Kerry J. Factors influencing the flavour of bovine milk and cheese from grass based versus non-grass based milk production systems. Foods 2018;7:E37.","DOI":"10.3390\/foods7030037"},{"key":"ref25","unstructured":"24. Lakhani N, Lakhani P. Plant secondary metabolites as a potential source to inhibit methane production and improve animal performance. Int J Chem Stud 2018"},{"key":"ref26","unstructured":"6:3375-9.http:\/\/www.chemijournal.com\/archives\/2018\/vol6issue3\/PartAW\/6-3-425-872.pdf (accessed November 7, 2019)."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1017\/S1751731110002296","article-title":"Traceability of grass feeding in beef: terpenes, 2,3-octanedione and skatole accumulation in adipose tissue of young bulls","volume":"5","author":"Serrano","year":"2011","unstructured":"25. Serrano E, Cornu A, Kondjoyan N, Agabriel J, Micol D. Traceability of grass feeding in beef: terpenes, 2,3-octanedione and skatole accumulation in adipose tissue of young bulls. Animal 2011;5:641-9.","journal-title":"Animal"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5713\/ajas.2003.282","article-title":"Herbs and botanicals for monogastric animals","volume":"16","author":"Wenk","year":"2003","unstructured":"26. Wenk C. Herbs and botanicals for monogastric animals. Asian-Aust J Anim Sci 2003;16:282-9.","journal-title":"Asian-Aust J Anim Sci"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"27. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Scientific opinion on the safety of hemp (Cannabis genus) for use as animal feed. EFSA J 2011;9:2011","DOI":"10.2903\/j.efsa.2011.2011"},{"key":"ref30","unstructured":"28. \u0160\u0165astn\u00edk O, Filip K, Hana S, et al. The effect of hempseed cakes on broiler chickens performance parameters. In: International Ph.D. Students Conference on MendelNet; 2015. Available at:"},{"key":"ref31","unstructured":"https:\/\/www.researchgate.net\/publication\/283715306_THE_EFFECT_OF_HEMPSEED_CAKES_ON_BROILER_CHICKENS_PERFORMANCE_PARAMETERS (accessed January 8, 2020)."},{"key":"ref32","unstructured":"29. Stastnik O, Karasek F, Stenclova H, et al. The effect of hemp by-products feeding on gut microbiota and growth of broiler chickens. In: International Ph.D. Students Conference on MendelNet; 2016. Available at: https:\/\/www.researchgate.net\/publication\/309772819_THE_EFFECT_OF_HEMP_BY-PRODUCTS_FEEDING_ON_GUT_MICROBIOTA_AND_GROWTH_OF_BROILER_CHICKENS (accessed November 19, 2019)."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/0071660500066183","article-title":"The effect of feeding hemp seed meal to laying hens","volume":"46","author":"Silversides","year":"2005","unstructured":"30. Silversides FG, Lefran\u00c7ois MR. The effect of feeding hemp seed meal to laying hens. Br Poult Sci 2005; 46:231-5.","journal-title":"Br Poult Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.4081\/ijas.2015.3473","article-title":") and dextran oligosaccharide on growth performance and antibody titer response of broiler chickens","volume":"14","author":"Mahmoudi","year":"2015","unstructured":"31. Mahmoudi M, Farhoomand P, Nourmohammadi R. Effects of different levels of hemp seed (Cannabis sativa L.) and dextran oligosaccharide on growth performance and antibody titer response of broiler chickens. Ital J Anim Sci 2015;14:3473.","journal-title":"Ital J Anim Sci"},{"key":"ref35","unstructured":"32. Kalmendal R. Hemp seed cake fed to broilers. Swedish Univ Agric Sci Dep Anim Nutr Manag 2008:4-15. Available at:"},{"key":"ref36","unstructured":"https:\/\/hemptechglobal.com\/resources\/Hemp_seed_cake_fed_to_broilers_-_R_Kalmendal.pdf (accessed January 8, 2020)."},{"key":"ref37","unstructured":"33. Sloss A. A feasibility study of industrial hemp on Virginia commercial poultry production. Senior Honors Projects, 2010-current. JMU Scholarly Commons 716. Published May 4, 2019. Available at: https:\/\/commons.lib.jmu.edu\/honors201019\/716 (accessed November 19, 2019)."},{"key":"ref38","unstructured":"34. US Food & Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products Including Cannabidiol. Question 24. I've seen cannabis products being marketed for pets. Are they safe? Available at: https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd (accessed November 10, 2019)."},{"key":"ref39","unstructured":"35. US Food & Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products Including Cannabidiol. Question 25. Can hemp be added to animal food? Available at:"},{"key":"ref40","unstructured":"https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#hempanimal (accessed January 12, 2020)."},{"key":"ref41","unstructured":"36. Buur J, Jeromin A, Powers J, et al. American Veterinary Medical Association (AVMA) council on biologic and therapeutic agents, cannabis: what veterinarians need to know; 2018. Available at:"},{"key":"ref42","unstructured":"https:\/\/www.svma.sk.ca\/uploads\/pdf\/Latest%20Items\/Cannabis-What-Veterinarians-Need-to-Know.pdf (accessed November 20, 2019)."},{"key":"ref43","unstructured":"37. DeFelice SL. From Oysters to Insulin: Nature and Medicine at Odds. Secaucus, NJ: Citadel Press; 1986. https:\/\/www.semanticscholar.org\/paper\/From-Oysters-to-Insulin%3A-Nature-and-Medicine-at-DeFelice\/a64f060f8ad6387062456be23a4767521fb723fb (accessed November 7, 2019)."},{"key":"ref44","unstructured":"38. Lawrence J. Diamond in the roughage: can foods prevent and treat disease? Pharm J 2016;296:25-8."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/0929867324666170920144130","article-title":"Nutraceuticals and \"repurposed\" drugs of phytochemical origin in prevention and interception of chronic degenerative diseases and cancer","volume":"26","author":"Albini","year":"2019","unstructured":"39. Albini A, Bassani B, Baci D, et al. Nutraceuticals and \"repurposed\" drugs of phytochemical origin in prevention and interception of chronic degenerative diseases and cancer. Curr Med Chem 2019;26:973-87.","journal-title":"Curr Med Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.biotechadv.2018.03.014","article-title":"Dietary nutraceuticals as backbone for bone health","volume":"36","author":"Pandey","year":"2018","unstructured":"40. Pandey MK, Gupta SC, Karelia D, Gilhooley PJ, Shakibaei M, Aggarwal BB. Dietary nutraceuticals as backbone for bone health. Biotechnol Adv 2018; 36:1633-48.","journal-title":"Biotechnol Adv"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"41. Di Francia R, Berretta M, Benincasa G, et al. Pharmacogenetic-based interactions between nutraceuticals and angiogenesis inhibitors. Cells 2019;8:E522.","DOI":"10.3390\/cells8060522"},{"key":"ref48","unstructured":"42. Scolaro B, Vaisar T, Fisher E, Castro I. Abstract 696: Reduced-dose statin therapy complemented with nutraceuticals alters HDL proteomics. Arterioscler Thromb Vasc Biol 2019;39(Suppl_1):A696. Available at: https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/atvb.39.suppl_1.696 (accessed November 7, 2019)."},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"43. Cicero AFG, Colletti A. Nutraceuticals Active on Immune System. In: Cicero AFG, Colletti A. Handbook of Nutraceuticals for Clinical Use. Cham, Switzerland: Springer International Publishing; 2018:163-79.","DOI":"10.1007\/978-3-319-73642-6_13"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"44. Colitti M, Stefanon B, Gabai G, Gelain ME, Bonsembiante F. Oxidative stress and nutraceuticals in the modulation of the immune function: current knowledge in animals of veterinary interest. Antioxidants 2019;8:E28.","DOI":"10.3390\/antiox8010028"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1139\/apnm-2018-0781","article-title":"Research in nutritional supplements and nutraceuticals for health, physical activity, and performance: moving forward","volume":"44","author":"Ward","year":"2019","unstructured":"45. Ward WE, Chilibeck PD, Comelli EM, et al. Research in nutritional supplements and nutraceuticals for health, physical activity, and performance: moving forward. Appl Physiol Nutr Metab 2019;44:455-60.","journal-title":"Appl Physiol Nutr Metab"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13555-018-0221-x","article-title":"Nutraceuticals: a review","volume":"8","author":"Souyoul","year":"2018","unstructured":"46. Souyoul SA, Saussy KP, Lupo MP. Nutraceuticals: a review. Dermatol Ther (Heidelb) 2018;8:5-16.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"47. Hartsel JA, Boyar K, Pham A, Silver RJ, Makriyannis A. Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals. In: Gupta RC, Srivastava A, Lall R, eds. Nutraceuticals in Veterinary Medicine. Cham, Switzerland: Springer International Publishing; 2019:121-55.","DOI":"10.1007\/978-3-030-04624-8_10"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"48. Gupta RC, Srivastava A, Lall R, eds. Nutraceuticals in Veterinary Medicine. Cham, Switzerland: Springer International Publishing; 2019.","DOI":"10.1007\/978-3-030-04624-8"},{"key":"ref55","unstructured":"49. US Food & Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products Including Cannabidiol. Question 9. Can THC or CBD products be sold as dietary supplements? Available at:"},{"key":"ref56","unstructured":"https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#dietarysupplements (accessed January 12, 2020)."},{"key":"ref57","unstructured":"50. US Food & Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products Including Cannabidiol. Question 10. Is it legal, in interstate commerce, to sell a food (including any animal food or feed) to which THC or CBD has been added? Available at: https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#food (accessed January 12, 2020)."},{"key":"ref58","unstructured":"51. US Food and Drug Administration (FDA). FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns. Published November 2019. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details (accessed November 26, 2019)."},{"key":"ref59","unstructured":"52. Abernethy A, Schiller L. FDA is committed to sound, science-based policy on CBD. Food and Drug Administration. Published 2019. Available at:"},{"key":"ref60","unstructured":"https:\/\/www.fda.gov\/news-events\/fda-voices-perspectives-fda-leadership-and-experts\/fda-committed-sound-science-based-policy-cbd (accessed November 26, 2019)."},{"key":"ref61","unstructured":"53. US Food and Drug Administration (FDA). Warning letters and test results for cannabidiol-related products. Published 2019. Available at:"},{"key":"ref62","unstructured":"https:\/\/www.fda.gov\/news-events\/public-health-focus\/warning-letters-and-test-results-cannabidiol-related-products (accessed November 26, 2019)."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/medicines5030093","article-title":"Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview","volume":"5","author":"Tungmunnithum","year":"2018","unstructured":"54. Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview. Medicines 2018; 5:93.","journal-title":"Medicines"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"55. Ahmed M, Sikandar A, Iqbal M, et al. Phytochemical screening, total phenolics and flavonoids content and antioxidant activities of Citrullus colocynthis L. and Cannabis sativa L. Appl Ecol Environ Res 2019; 17:6961-79.","DOI":"10.15666\/aeer\/1703_69616979"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"56. Wallace T, Cassidy A, Chung M, et al. Tea flavonoids and risk of cardiovascular and all-cause mortality: a systematic review and meta-analysis (P06-126-19). Current Developments in Nutrition 2019;3(Suppl 1): nzz031.P06-126-19.","DOI":"10.1093\/cdn\/nzz031.P06-126-19"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/BF02118655","article-title":"Cannflavin A and B, prenylated flavones from Cannabis sativa L","volume":"42","author":"Barrett","year":"1986","unstructured":"57. Barrett ML, Scutt AM, Evans FJ. Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 1986;42:452-3.","journal-title":"Experientia"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0031-9422(96)00344-5","article-title":"Isoprenylated flavonoids-a survey","volume":"43","author":"Barron","year":"1996","unstructured":"58. Barron D, Ibrahim RK. Isoprenylated flavonoids-a survey. Phytochemistry 1996;43:921-82.","journal-title":"Phytochemistry"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phanu.2014.05.001","article-title":"Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"2","author":"Werz","year":"2014","unstructured":"59. Werz O, Seegers J, Schaible AM, et al. Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. Pharma Nutrition 2014;2:53-60.","journal-title":"Pharma Nutrition"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/j.phytochem.2008.07.010","article-title":"Non-cannabinoid constituents from a high potency Cannabis sativa variety","volume":"69","author":"Radwan","year":"2008","unstructured":"60. Radwan MM, Elsohly MA, Slade D, et al. Non-cannabinoid constituents from a high potency Cannabis sativa variety. Phytochemistry 2008;69:2627-33.","journal-title":"Phytochemistry"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"61. Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci 2016;5:e47.","DOI":"10.1017\/jns.2016.41"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"113609","DOI":"10.1016\/j.bcp.2019.08.011","article-title":"Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid \u03b2-mediated neurotoxicity in PC12 cells: comparison with geranylated flavonoids, mimulone and diplacone","volume":"169","author":"Eggers","year":"2019","unstructured":"62. Eggers C, Fujitani M, Kato R, Smid S. Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid \u03b2-mediated neurotoxicity in PC12 cells: comparison with geranylated flavonoids, mimulone and diplacone. Biochem Pharmacol 2019;169:113609.","journal-title":"Biochem Pharmacol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/0004-282x20180147","article-title":"The anticonvulsant effects of Ducrosia anethifolia (Boiss) essential oil are produced by its main component alpha-pinene in rats","volume":"77","author":"Zamyad","year":"2019","unstructured":"63. Zamyad M, Abbasnejad M, Esmaeili-Mahani S, Mostafavi A, Sheibani V. The anticonvulsant effects of Ducrosia anethifolia (Boiss) essential oil are produced by its main component alpha-pinene in rats. Arq Neuropsiquiatr 2019;77:106-14.","journal-title":"Arq Neuropsiquiatr"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jtcme.2017.03.001","article-title":"leaves on pentylenetetrazol induced seizure in mice","volume":"8","author":"Herrera-Calderon","year":"2018","unstructured":"64. Herrera-Calderon O, Santiv\u00e1\u00f1ez-Acosta R, Pari-Olarte B, Enciso-Roca E, Campos Montes VM, Luis Arroyo Acevedo J. Anticonvulsant effect of ethanolic extract of Cyperus articulatus L. leaves on pentylenetetrazol induced seizure in mice. J Tradit Complement Med 2018;8:95-9.","journal-title":"J Tradit Complement Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1099\/jmm.0.000105","article-title":"Limonene inhibits streptococcal biofilm formation by targeting surface-associated virulence factors","volume":"64","author":"Subramenium","year":"2015","unstructured":"65. Subramenium GA, Vijayakumar K, Pandian SK. Limonene inhibits streptococcal biofilm formation by targeting surface-associated virulence factors. J Med Microbiol 2015;64:879-90.","journal-title":"J Med Microbiol"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"66. Guimar\u00e3es AC, Meireles LM, Lemos MF, et al. Antibacterial activity of terpenes and terpenoids present in essential oils. Molecules 2019;24:pii:E2471.","DOI":"10.3390\/molecules24132471"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1021\/acs.jafc.7b00497","article-title":"Potential contribution of fish feed and phytoplankton to the content of volatile terpenes in cultured pangasius (Pangasianodon hypophthalmus) and tilapia (Oreochromis niloticus)","volume":"65","author":"Podduturi","year":"2017","unstructured":"67. Podduturi R, Petersen MA, Mahmud S, Rahman MM, J\u00f8rgensen NOG. Potential contribution of fish feed and phytoplankton to the content of volatile terpenes in cultured pangasius (Pangasianodon hypophthalmus) and tilapia (Oreochromis niloticus). J Agric Food Chem 2017;65:3730-6.","journal-title":"J Agric Food Chem"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phytochem.2019.03.021","article-title":"Hoo with their TNF-\u03b1 and IL-6 inhibitory activities","volume":"163","author":"Li","year":"2019","unstructured":"68. Li F, Zhang J, Lin M, et al. Anti-inflammatory terpenes from Schefflera rubriflora C. J. Tseng & G. Hoo with their TNF-\u03b1 and IL-6 inhibitory activities. Phytochemistry 2019;163:23-32.","journal-title":"Phytochemistry"},{"key":"ref78","unstructured":"69. Vega RJS, Xolalpa NC, Castro AJA, Gonz\u00e1lez CP, Ramos JP, Guti\u00e9rrez SP. Terpenes from Natural Products with Potential Anti-inflammatory Activity. In: Perveen S, Al-Taweel A, eds. Terpenes and Terpenoids. London, UK: IntechOpen Limited; 2018. ."},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"70. Smith Grace SR, Girish C, Jyoti BC. Terpenoids: An Activator of \"Fuel-sensing Enzyme AMPK\" with Special Emphasis on Antidiabetic Activity. In: Ozturk M, Hakeem K, eds. Plant and Human Health, volume 2. Cham, Switzerland: Springer Nature; 2019:227-44.","DOI":"10.1007\/978-3-030-03344-6_9"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10787-018-0483-z","article-title":"In vitro anti-inflammatory activity of terpenes via suppression of superoxide and nitric oxide generation and the NF-\u03baB signalling pathway","volume":"27","author":"Marques","year":"2019","unstructured":"71. Marques FM, Figueira MM, Schmitt EFP, et al. In vitro anti-inflammatory activity of terpenes via suppression of superoxide and nitric oxide generation and the NF-\u03baB signalling pathway. Inflammopharmacology 2019;27:281-9.","journal-title":"Inflammopharmacology"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.phymed.2018.10.028","article-title":"Terpenes as possible drugs for the mitigation of arthritic symptoms - a systematic review","volume":"57","author":"Carvalho","year":"2019","unstructured":"72. Carvalho AMS, Heimfarth L, Santos KA, et al. Terpenes as possible drugs for the mitigation of arthritic symptoms - a systematic review. Phytomedicine 2019;57:137-47.","journal-title":"Phytomedicine"},{"key":"ref82","unstructured":"73. Kubacka M, Librowski T, Czarnecki R, Frackowiak B, Lochy\u0144ski S. Anticonvulsant and antidepressant activity of the selected terpene GABA derivatives in experimental tests in mice. Pharmacol Rep 2006; 58:936-43."},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"74. Ferber SG, Namdar D, Hen-Shoval D, et al. The \"entourage effect\": terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Curr Neuropharmacol 2019;17. [Epub ahead of print]","DOI":"10.2174\/1570159X17666190903103923"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"75. Inoue M, Hayashi S, Craker LE. Role of Medicinal and Aromatic Plants: Past, Present, and Future. In: Perveen S, Al-Taweel A, eds. Pharmacognosy - Medicinal Plants. London, UK: IntechOpen Limited; 2019.","DOI":"10.5772\/intechopen.82497"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/00071668.2018.1483577","article-title":"Effect of herbal feed additives on performance parameters, intestinal microbiota, intestinal morphology and meat lipid oxidation of broiler chickens","volume":"59","author":"Giannenas","year":"2018","unstructured":"76. Giannenas I, Bonos E, Skoufos I, et al. Effect of herbal feed additives on performance parameters, intestinal microbiota, intestinal morphology and meat lipid oxidation of broiler chickens. Br Poult Sci 2018;59:545-53.","journal-title":"Br Poult Sci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40104-015-0004-5","article-title":"Essential oil and aromatic plants as feed additives in non-ruminant nutrition: a review","volume":"6","author":"Zeng","year":"2015","unstructured":"77. Zeng Z, Zhang S, Wang H, Piao X. Essential oil and aromatic plants as feed additives in non-ruminant nutrition: a review. J Anim Sci Biotechnol 2015;6:7.","journal-title":"J Anim Sci Biotechnol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3168\/jds.2016-11761","article-title":"Changes in terpenoid composition of milk and cheese from commercial sheep flocks associated with seasonal feeding regimens throughout lactation","volume":"100","author":"Valdivielso","year":"2017","unstructured":"78. Valdivielso I, de Renobales M, Aldai N, Barron LJR. Changes in terpenoid composition of milk and cheese from commercial sheep flocks associated with seasonal feeding regimens throughout lactation. J Dairy Sci 2017;100:96-105.","journal-title":"J Dairy Sci"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fchem.2018.00241","article-title":"Odorants in fish feeds: a potential source of malodors in aquaculture","volume":"6","author":"Mahmoud","year":"2018","unstructured":"79. Mahmoud MAA, Tybussek T, Loos HM, Wagenstaller M, Buettner A. Odorants in fish feeds: a potential source of malodors in aquaculture. Front Chem 2018; 6:241.","journal-title":"Front Chem"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23937\/2378-3001\/2\/2\/1032","article-title":"Citicoline treatment improves measures of impulsivity and task performance in chronic marijuana smokers: a Pilot BOLD fMRI Study","volume":"2","author":"Gruber","year":"2015","unstructured":"80. Gruber SA, Sagar KA, Dahlgren MK, et al. Citicoline treatment improves measures of impulsivity and task performance in chronic marijuana smokers: a Pilot BOLD fMRI Study. Int J Neurol Neurother 2015;2:1-8.","journal-title":"Int J Neurol Neurother"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3201\/eid0701.010102","article-title":"Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns","volume":"7","author":"Brown","year":"2001","unstructured":"81. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis 2001;7:6-16.","journal-title":"Emerg Infect Dis"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.etap.2007.10.003","article-title":"An overview","volume":"25","author":"Covaci","year":"2008","unstructured":"82. Covaci A, Voorspoels S, Schepens P, Jorens P, Blust R, Neels H. The Belgian PCB\/dioxin crisis-8 years later. An overview. Environ Toxicol Pharmacol 2008; 25:164-70.","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref92","unstructured":"83. Centers for Disease Control and Prevention (CDC). Selected Publications. Listeria | CDC. Available at: https:\/\/www.cdc.gov\/listeria\/publications.html (accessed November 10, 2019)."},{"key":"ref93","unstructured":"84. The Global Food Safety Initiative (GFSI). Overview - MyGFSI. The Global Food Safety Initiative (GFSI). Available at: https:\/\/mygfsi.com\/who-we-are\/overview\/ (accessed November 10, 2019)."},{"key":"ref94","unstructured":"85. FSSC 22000. The Foundation Food Safety System Certification 22000. Published 2018. Available at: https:\/\/www.fssc22000.com\/ (accessed November 11, 2019)."},{"key":"ref95","unstructured":"86. US Food & Drug Administration. Full Text of the Food Safety Modernization Act (FSMA). FDA. Available at: https:\/\/www.fda.gov\/food\/food-safety-mod-ernization-act-fsma\/full-text-food-safety-moderni-zation-act-fsma (accessed November 10, 2019)."},{"key":"ref96","unstructured":"87. US Food & Drug Administration. FSMA compliance dates. Available at: https:\/\/www.fda.gov\/food\/food-safety-modernization-act-fsma\/fsma-compliance-dates (accessed November 10, 2019)."},{"key":"ref97","unstructured":"88. US Food & Drug Administration. Center for Veterinary Medicine. CVM GFI #245 Hazard analysis and risk-based preventive controls for food for animals. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cvm-gfi-245-hazard-analysis-and-risk-based-preventive-controls-food-animals (accessed November 10, 2019)."},{"key":"ref98","unstructured":"89. European Food Safety Authority (EFSA). Scientific topic: Foodborne zoonotic diseases. Available at: https:\/\/www.efsa.europa.eu\/en\/topics\/topic\/foodborne-zoonotic-diseases (accessed November 11, 2019)."},{"key":"ref99","unstructured":"90. US Food & Drug Administration (FDA). People at risk of foodborne illness. Available at:"},{"key":"ref100","unstructured":"https:\/\/www.fda.gov\/food\/consumers\/people-risk-foodborne-illness (accessed November 11, 2019)."},{"key":"ref101","unstructured":"91. World Health Organization. Food safety. Published 2019. Available at: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/food-safety (accessed November 11, 2019)."},{"key":"ref102","unstructured":"92. European Food Safety Authority (EFSA). Scientific topic: Biological hazards. Available at: https:\/\/www.efsa.europa.eu\/en\/topics\/topic\/biological-hazards (accessed November 11, 2019)."},{"key":"ref103","unstructured":"93. Center for Food Safety and Applied Nutrition, Food and Drug Administration (FDA), US Department of Health and Human Services. Bad Bug Book Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins. Available at: https:\/\/www.fda.gov\/media\/83271\/download (accessed January 9, 2020)"},{"key":"ref104","unstructured":"94. World Health Organization (WHO). Listeriosis. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/listeriosis (accessed November 13, 2019)."},{"key":"ref105","unstructured":"95. European Food Safety Authority (EFSA). Scientific topic: Listeria. Published 2019. Available at: https:\/\/www.efsa.europa.eu\/en\/topics\/topic\/listeria (accessed November 13, 2019)."},{"key":"ref106","unstructured":"96. Centers for Disease Control and Prevention (CDC). Listeria outbreaks. Available at:"},{"key":"ref107","unstructured":"https:\/\/www.cdc.gov\/listeria\/outbreaks\/index.html (accessed November 13, 2019)."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fcimb.2018.00293","article-title":"essential oil","volume":"8","author":"Marini","year":"2018","unstructured":"97. Marini E, Magi G, Ferretti G, et al. Attenuation of Listeria monocytogenes virulence by Cannabis sativa L. essential oil. Front Cell Infect Microbiol 2018; 8:293.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref109","unstructured":"98. World Health Organization. Chagas disease (American trypanosomiasis). Published 2019. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis) (accessed November 11, 2019)."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000481824","article-title":"Immunoregulatory role of cannabinoids during infectious disease","volume":"24","author":"Hern\u00e1ndez-Cervantes","year":"2017","unstructured":"99. Hern\u00e1ndez-Cervantes R, M\u00e9ndez-D\u00edaz M, Prosp\u00e9ro-Garc\u00eda \u00d3, Morales-Montor J. Immunoregulatory role of cannabinoids during infectious disease. Neuroimmunomodulation 2017;24:183-99.","journal-title":"Neuroimmunomodulation"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/j.1462-5822.2005.00577.x","article-title":"Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression","volume":"7","author":"Croxford","year":"2005","unstructured":"100. Croxford JL, Wang K, Miller SD, Engman DM, Tyler KM. Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression. Cell Microbiol 2005;7:1592-602.","journal-title":"Cell Microbiol"},{"key":"ref112","unstructured":"101. Pan American Health Organization (PAHO), World Health Organization (WHO). Country report: Panama. Available at: https:\/\/www.paho.org\/salud-en-las-americas-2017\/?page_id=145 (accessed November 11, 2019)."},{"key":"ref113","unstructured":"102. Pan American Health Organization (PAHO), World Health Organization (WHO). Panama. Leading health challenges. Available at: https:\/\/www.paho.org\/salud-en-las-americas-2017\/?p=4289 (accessed November 11, 2019)."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.vetpar.2007.08.004","article-title":"Serological survey of Leishmania infantum and Trypanosoma cruzi in dogs from urban areas of Brazil and Colombia","volume":"149","author":"Rosypal","year":"2007","unstructured":"103. Rosypal AC, Cort\u00e9s-Vecino JA, Gennari SM, Dubey JP, Tidwell RR, Lindsay DS. Serological survey of Leishmania infantum and Trypanosoma cruzi in dogs from urban areas of Brazil and Colombia. Vet Parasitol 2007;149:172-7.","journal-title":"Vet Parasitol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.vetpar.2010.12.043","article-title":"Prevalence of trypanosome infections in dogs from Chagas disease endemic regions in Panama, Central America","volume":"178","author":"Pineda","year":"2011","unstructured":"104. Pineda V, Salda\u00f1a A, Monfante I, et al. Prevalence of trypanosome infections in dogs from Chagas disease endemic regions in Panama, Central America. Vet Parasitol 2011;178:360-3.","journal-title":"Vet Parasitol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s10393-019-01434-2","article-title":"Giardia infection and Trypanosoma Cruzi exposure in dogs in the Bosaw\u00e1s biosphere reserve, Nicaragua","volume":"16","author":"Roegner","year":"2019","unstructured":"105. Roegner AF, Daniels ME, Smith WA, et al. Giardia infection and Trypanosoma Cruzi exposure in dogs in the Bosaw\u00e1s biosphere reserve, Nicaragua. Ecohealth 2019;16:512-22.","journal-title":"Ecohealth"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/vbz.2017.2258","article-title":"Efficacy of recombinase polymerase amplification to diagnose Trypanosoma cruzi infection in dogs with cardiac alterations from an endemic area of Mexico","volume":"18","author":"Jimenez-Coello","year":"2018","unstructured":"106. Jimenez-Coello M, Shelite T, Castellanos-Gonzalez A, et al. Efficacy of recombinase polymerase amplification to diagnose Trypanosoma cruzi infection in dogs with cardiac alterations from an endemic area of Mexico. Vector Borne Zoonotic Dis 2018;18:417-23.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref118","unstructured":"107. World Health Organization (WHO). Surveillance of leishmaniasis in the WHO European Region, 2016. Weekly epidemiological record 2018;93:521-540. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/275333\/WER9340.pdf?ua=1 (accessed January 21, 2020)."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3201\/eid2504.180239","article-title":"Mucosal Leishmaniasis in travelers with Leishmania braziliensis complex returning to Israel","volume":"25","author":"Solomon","year":"2019","unstructured":"108. Solomon M, Sahar N, Pavlotzky F, et al. Mucosal Leishmaniasis in travelers with Leishmania braziliensis complex returning to Israel. Emerg Infect Dis 2019;25:642-8.","journal-title":"Emerg Infect Dis"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.meegid.2016.07.035","article-title":"Increased prevalence of human cutaneous leishmaniasis in Israel and the Palestinian Authority caused by the recent emergence of a population of genetically similar strains of Leishmania tropica","volume":"50","author":"Azmi","year":"2017","unstructured":"109. Azmi K, Krayter L, Nasereddin A, et al. Increased prevalence of human cutaneous leishmaniasis in Israel and the Palestinian Authority caused by the recent emergence of a population of genetically similar strains of Leishmania tropica. Infect Genet Evol 2017;50:102-9.","journal-title":"Infect Genet Evol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4269\/ajtmh.17-0370","article-title":"Serological evaluation of cutaneous Leishmania tropica infection in northern Israel","volume":"98","author":"Spitzov\u00e1","year":"2018","unstructured":"110. Spitzov\u00e1 T, Rohou\u0161ov\u00e1 I, Volf P, et al. Serological evaluation of cutaneous Leishmania tropica infection in northern Israel. Am J Trop Med Hyg 2018;98:139-41.","journal-title":"Am J Trop Med Hyg"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1515\/ap-2016-0118","article-title":"Cutaneous leishmaniasis caused by Leishmania infantum in southern Israel","volume":"61","author":"Ben-Shimol","year":"2016","unstructured":"111. Ben-Shimol S, Sagi O, Horev A, Avni YS, Ziv M, Riesenberg K. Cutaneous leishmaniasis caused by Leishmania infantum in southern Israel. Acta Parasitol 2016;61:855-8.","journal-title":"Acta Parasitol"},{"key":"ref123","unstructured":"112. World Health Organization (WHO). WHO report on global surveillance of epidemic-prone infectious diseases - Leishmaniasis. Published 2015. Available at: https:\/\/www.who.int\/csr\/resources\/publications\/CSR_ISR_2000_1leish\/en\/ (accessed November 17, 2019)."},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"113. Ibarra-Meneses AV, Carrillo E, Nieto J, et al. Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015. Eurosurveillance 2019;24:pii=1800379","DOI":"10.2807\/1560-7917.ES.2019.24.22.1800379"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/tbed.13186","article-title":"Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis","volume":"66","author":"Razavinasab","year":"2019","unstructured":"114. Razavinasab SZ, Sharifi I, Aflatoonian MR, et al. Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis. Transbound Emerg Dis 2019;66:1602-10.","journal-title":"Transbound Emerg Dis"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2478\/s11686-019-00043-x","article-title":"Prevalence of endoparasites in urban stray dogs from Brazil diagnosed with Leishmania, with potential for human zoonoses","volume":"64","author":"Saldanha-Elias","year":"2019","unstructured":"115. Saldanha-Elias AM, Silva MA, Silva VO, et al. Prevalence of endoparasites in urban stray dogs from Brazil diagnosed with Leishmania, with potential for human zoonoses. Acta Parasitol 2019;64:352-9.","journal-title":"Acta Parasitol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/trstmh\/trx080","article-title":"Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak","volume":"111","author":"\u00c1LM","year":"2017","unstructured":"116. Lima \u00c1LM, de Lima ID, Coutinho JFV, et al. Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak. Trans R Soc Trop Med Hyg 2017;111:440-7.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1590\/0037-8682-0074-2018","article-title":"Epidemiology of human visceral leishmaniasis in the urban centers of the lower-middle S\u00e3o Francisco Valley, Brazilian semiarid region","volume":"51","author":"Diniz","year":"2018","unstructured":"117. Diniz LFB, de Souza CDF, do Carmo RF. Epidemiology of human visceral leishmaniasis in the urban centers of the lower-middle S\u00e3o Francisco Valley, Brazilian semiarid region. Rev Soc Bras Med Trop 2018;51:461-6.","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"118. Inceboz T. Epidemiology and Ecology of Leishmaniasis. In: Rodriguez-Morales AJ, ed. Current Topics in Neglected Tropical Diseases. London, UK: IntechOpen Limited; 2019.","DOI":"10.5772\/intechopen.86359"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3201\/eid1309.070101","article-title":"Stray dogs and leishmaniasis in urban areas, Portugal","volume":"13","author":"Cortes","year":"2007","unstructured":"119. Cortes S, Afonso MO, Alves-Pires C, Campino L. Stray dogs and leishmaniasis in urban areas, Portugal. Emerg Infect Dis 2007;13:1431-2.","journal-title":"Emerg Infect Dis"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3201\/eid2502.181359","article-title":"Identification of Leishmania species in naturally infected sand flies from refugee camps, Greece","volume":"25","author":"Fotakis","year":"2019","unstructured":"120. Fotakis EA, Giantsis IA, Avgerinou A, et al. Identification of Leishmania species in naturally infected sand flies from refugee camps, Greece. Emerg Infect Dis 2019;25:361-364.","journal-title":"Emerg Infect Dis"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00436-019-06392-w","article-title":"The impact of refugees on leishmaniasis in Turkey: a new Syrian\/Turkish Leishmania tropica population structure described by multilocus microsatellite typing (MLMT)","volume":"118","author":"Karaku\u015f","year":"2019","unstructured":"121. Karaku\u015f M, \u00c7izmeci Z, Karabela \u015eN, Erdo\u011fan B, G\u00fcle\u00e7 N. The impact of refugees on leishmaniasis in Turkey: a new Syrian\/Turkish Leishmania tropica population structure described by multilocus microsatellite typing (MLMT). Parasitol Res 2019;118: 2679-87.","journal-title":"Parasitol Res"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1073\/pnas.1810435115","article-title":"Plant-feeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa","volume":"115","author":"Abbasi","year":"2018","unstructured":"122. Abbasi I, Trancoso Lopo de Queiroz A, Kirstein OD, et al. Plant-feeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa. Proc Natl Acad Sci U S A 2018;115:11790-5.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref134","unstructured":"123. McPartland JM, Sheikh Z. A review of Cannabis sativa-based insecticides, miticides, and repellents. J Entomol Zool Stud 2018;6:1288-99. Available at: http:\/\/www.entomoljournal.com\/archives\/2018\/vol6issue6\/PartV\/6-6-173-373.pdf (accessed November 18, 2019)."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jmgm.2013.12.010","article-title":"Antileishmanial phytochemical phenolics: molecular docking to potential protein targets","volume":"48","author":"Ogungbe","year":"2014","unstructured":"124. Ogungbe IV, Erwin WR, Setzer WN. Antileishmanial phytochemical phenolics: molecular docking to potential protein targets. J Mol Graph Model 2014;48:105-117.","journal-title":"J Mol Graph Model"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1021\/np900067k","article-title":"Biologically active cannabinoids from high-potency Cannabis sativa","volume":"72","author":"Radwan","year":"2009","unstructured":"125. Radwan MM, ElSohly MA, Slade D, Ahmed SA, Khan IA, Ross SA. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod 2009; 72:906-11.","journal-title":"J Nat Prod"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.phytochem.2015.04.007","article-title":"Minor oxygenated cannabinoids from high potency Cannabis sativa L","volume":"117","author":"Ahmed","year":"2015","unstructured":"126. Ahmed SA, Ross SA, Slade D, Radwan MM, Khan IA, ElSohly MA. Minor oxygenated cannabinoids from high potency Cannabis sativa L. Phytochemistry 2015;117:194-9.","journal-title":"Phytochemistry"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/can.2018.0043","article-title":"Oral ingestion of Cannabis sativa: risks, benefits, and effects on malaria-infected hosts","volume":"3","author":"Akinola","year":"2018","unstructured":"127. Akinola O, Ogbeche EO, Olumoh-Abdul HA, et al. Oral ingestion of Cannabis sativa: risks, benefits, and effects on malaria-infected hosts. Cannabis Cannabinoid Res 2018;3:219-27.","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"574","DOI":"10.6026\/97320630014574","article-title":"Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR","volume":"14","author":"David","year":"2018","unstructured":"128. David TI, Adelakun NS, Omotuyi OI, et al. Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR. Bioinformation 2018;14:574-9.","journal-title":"Bioinformation"},{"key":"ref140","unstructured":"129. Ab\u00e9 H. Insecticidal activity of Cannabis sativa L leaf essential oil on the malaria vector Anopheles gambiae s.l (Giles). Int J Mosq Res 2018;5:65-74. Available at: http:\/\/www.dipterajournal.com\/pdf\/2018\/vol5issue4\/PartA\/5-3-19-653.pdf (accessed November 17, 2019)."},{"key":"ref141","unstructured":"130. World Health Organization (WHO). The world malaria report 2019. Available at: https:\/\/www.who.int\/publications-detail\/world-malaria-report-2019 (accessed January 9, 2020)."},{"key":"ref142","unstructured":"131. World Health Organization (WHO). The world malaria report 2018. Available at: https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/en\/ (accessed November 17, 2019)."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/cam4.1347","article-title":"Epidemiology of multiple myeloma in 17 Latin American countries: an update","volume":"7","author":"Curado","year":"2018","unstructured":"132. Curado MP, Oliveira MM, Silva DRM, Souza DLB. Epidemiology of multiple myeloma in 17 Latin American countries: an update. Cancer Med 2018;7:2101-8.","journal-title":"Cancer Med"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/01635581.2013.761255","article-title":"Meat, milk and risk of lymphoid malignancies: a case-control study in Uruguay","volume":"65","author":"De Stefani","year":"2013","unstructured":"133. De Stefani E, Ronco AL, Deneo-Pellegrini H, et al. Meat, milk and risk of lymphoid malignancies: a case-control study in Uruguay. Nutr Cancer 2013;65:375-83.","journal-title":"Nutr Cancer"},{"key":"ref145","unstructured":"134. Xie X-q, Yang P, Feng R, inventors; University of Pittsburgh, Pittsburgh PA, USA, assignee. Novel cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases. United States Patent No.: US 8,772,541 B2. Date of Patent: July 8, 2014. The United States Patent and Trademark Office (USPTO). https:\/\/patentimages.storage.googleapis.com\/17\/3b\/47\/41b3f21b2a25b0\/US8772541.pdf (accessed January 12, 2020)."},{"key":"ref146","unstructured":"135. Sinai A, Turner Z, Baruch Y, inventors; One World Cannabis Ltd, Petach Tikva, Israel, assignee. Novel cannabinoid combination therapies for multiple myeloma (MM). United States Patent Application: 0185324 A1 (July 5, 2018). The United States Patent and Trademark Office (USPTO). https:\/\/patentimages.storage.googleapis.com\/a8\/96\/87\/d38e1972d04337\/US20180185324A1.pdf (accessed January 12, 2020)."},{"key":"ref147","unstructured":"136. Stott C, Nabissi M, inventors; GW Research Ltd, Cambridge, UK, applicant. Use of cannabinoids in the treatment of multiple myeloma. United States Patent Application: 0190175547 (June 13, 2019). The United States Patent and Trademark Office (USPTO). https:\/\/patentimages.storage.googleapis.com\/f0\/da\/ac\/7579957c2fde81\/US20190175547A1.pdf (accessed January 12, 2020)."},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"137. Strong T, Rauvolfova J, Jackson E, et al. Novel formulation of cannabinoid analogues used in cancer therapy. J Clin Oncol 2018;36(15_suppl):e19536.","DOI":"10.1200\/JCO.2018.36.15_suppl.e19536"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21767\/2573-5349.100021","article-title":"In vitro influence of different fatty acids on the pharmacological effect of temozolomide","volume":"3","author":"Maor","year":"2018","unstructured":"138. Maor Y, Benadiba M, AlmogiHazan O, Serruya R, Or R. In vitro influence of different fatty acids on the pharmacological effect of temozolomide. J Transl Neurosci 2018;3:8.","journal-title":"J Transl Neurosci"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/ijms20030668","article-title":"Cannabinoids reduce inflammation but inhibit lymphocyte recovery in murine models of bone marrow transplantation","volume":"20","author":"Khuja","year":"2019","unstructured":"139. Khuja I, Yekhtin Z, Or R, Almogi-Hazan O. Cannabinoids reduce inflammation but inhibit lymphocyte recovery in murine models of bone marrow transplantation. Int J Mol Sci 2019;20:668.","journal-title":"Int J Mol Sci"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1939-165X.2005.tb00059.x","article-title":"Multiple myeloma in 16 cats: a retrospective study","volume":"34","author":"Patel","year":"2005","unstructured":"140. Patel RT, Caceres A, French AF, McManus PM. Multiple myeloma in 16 cats: a retrospective study. Vet Clin Pathol 2005;34:341-52.","journal-title":"Vet Clin Pathol"},{"key":"ref152","unstructured":"141. Sernberg R, Wypig J. An overview of multiple myeloma in dogs and cats. Vet Med 2009;104:468-76. http:\/\/veterinarymedicine.dvm360.com\/overview-multiple-myeloma-dogs-and-cats?id=&pageID=1&sk=&date= (accessed November 12, 2019)."},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"142. Mun\u0303oz A, Riber C, Satue\u0301 K, Trigo P, Go\u0301mez-Di\u0301ez M, Castejo\u0301n FM. Multiple Myeloma in Horses, Dogs and Cats: A Comparative Review Focused on Clinical Signs and Pathogenesis. In: Hajek R, ed. Multiple Myeloma - A Quick Reflection on the Fast Progress. London, UK: IntechOpen Limited; 2013.","DOI":"10.5772\/54311"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1939-1676.2006.tb01811.x","article-title":"A retrospective study of the incidence and the classification of bone marrow disorders in the dog at a veterinary teaching hospital (1996-2004)","volume":"20","author":"Weiss","year":"2006","unstructured":"143. Weiss DJ. A retrospective study of the incidence and the classification of bone marrow disorders in the dog at a veterinary teaching hospital (1996-2004). J Vet Intern Med 2006;20:955-61.","journal-title":"J Vet Intern Med"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1748-5827.2012.01247.x","article-title":"Geriatric screening in first opinion practice - results from 45 dogs","volume":"53","author":"Davies","year":"2012","unstructured":"144. Davies M. Geriatric screening in first opinion practice - results from 45 dogs. J Small Anim Pract 2012; 53:507-13.","journal-title":"J Small Anim Pract"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/1098612X16649523","article-title":"Aging in cats: common physical and functional changes","volume":"18","author":"Bellows","year":"2016","unstructured":"145. Bellows J, Center S, Daristotle L, et al. Aging in cats: common physical and functional changes. J Feline Med Surg 2016;18:533-50.","journal-title":"J Feline Med Surg"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"146. Landsberg GM, Malamed R. Clinical Picture of Canine and Feline Cognitive Impairment. In: Landsberg G, Madari A, Zilka N, eds. Canine and Feline Dementia: Molecular Basis, Diagnostics and Therapy. Cham, Switzerland: Springer International Publishing; 2017:1-12.","DOI":"10.1007\/978-3-319-53219-6_1"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tvjl.2009.11.007","article-title":"Under diagnosis of canine cognitive dysfunction: a cross-sectional survey of older companion dogs","volume":"184","author":"Salvin","year":"2010","unstructured":"147. Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. Under diagnosis of canine cognitive dysfunction: a cross-sectional survey of older companion dogs. Vet J 2010;184:277-81.","journal-title":"Vet J"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.applanim.2015.08.034","article-title":"Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES)","volume":"171","author":"Madari","year":"2015","unstructured":"148. Madari A, Farbakova J, Katina S, et al. Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES). Appl Anim Behav Sci 2015;171:138-45.","journal-title":"Appl Anim Behav Sci"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12603-015-0636-3","article-title":"Nutritional interventions that slow the age-associated decline in renal function in a canine geriatric model for elderly humans","volume":"20","author":"Hall","year":"2016","unstructured":"149. Hall JA, Yerramilli M, Obare E, et al. Nutritional interventions that slow the age-associated decline in renal function in a canine geriatric model for elderly humans. J Nutr Heal Aging 2016;20:1010-23.","journal-title":"J Nutr Heal Aging"},{"key":"ref161","doi-asserted-by":"publisher","unstructured":"150. Day MJ. Ageing, immunosenescence and inflammageing in the dog and cat. J Comp Pathol 2010; 142(suppl 1):S60-9.","DOI":"10.1016\/j.jcpa.2009.10.011"},{"key":"ref162","unstructured":"151. Kumar K, Agrawal R, Pande N, Sharma S, Kumar H. Occurrence, clinico-haemato-biochemical and histopathological studies on mammary gland tumor in geriatric dogs. Pharma Innov J 2018;7:301-4. Available at: https:\/\/pdfs.semanticscholar.org\/bc4e\/a8dfb44e5b7e604f2e97677d9f997c2a12e0.pdf"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2460\/javma.254.11.1301","article-title":"Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy","volume":"254","author":"McGrath","year":"2019","unstructured":"152. McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc 2019;254:1301-8.","journal-title":"J Am Vet Med Assoc"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fvets.2018.00165","article-title":"Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs","volume":"5","author":"L-J","year":"2018","unstructured":"153. Gamble L-J, Boesch JM, Frye CW, et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Front Vet Sci 2018; 5:165.","journal-title":"Front Vet Sci"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","unstructured":"154. Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res 2017;2:139-54.","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref166","unstructured":"155. Kogan LR, Hellyer PW, Silcox S, Schoenfeld-Tacher R. Canadian dog owners' use and perceptions of cannabis products. Canadian Vet J 2019;60:749-55."},{"key":"ref167","unstructured":"156. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res 2018;82:178-83."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fvets.2018.00338","article-title":"US veterinarians' knowledge, experience, and perception regarding the use of cannabidiol for canine medical conditions","volume":"5","author":"Kogan","year":"2019","unstructured":"157. Kogan L, Schoenfeld-Tacher R, Hellyer P, Rishniw M. US veterinarians' knowledge, experience, and perception regarding the use of cannabidiol for canine medical conditions. Front Vet Sci 2019;5:338.","journal-title":"Front Vet Sci"},{"key":"ref169","unstructured":"158. Gretler C, Craig G. The CBD industry is betting that pets need to chill, too. July 17, 2019, Bloomberg Businessweek. Available at: https:\/\/www.bloomberg.com\/news\/articles\/2019-07-17\/the-cbd-industry-is-betting-that-pets-need-to-chill-too (accessed November 10, 2019)."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.cvsm.2018.07.008","article-title":"Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats","volume":"48","author":"Brutlag","year":"2018","unstructured":"159. Brutlag A, Hommerding H. Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats. Vet Clin North Am Small Anim Pract 2018;48: 1087-102.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1476-4431.2012.00818.x","article-title":"Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010)","volume":"22","author":"Meola","year":"2012","unstructured":"160. Meola SD, Tearney CC, Haas SA, Hackett TB, Mazzaferro EM. Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010). J Vet Emerg Crit Care (San Antonio) 2012;22:690-6.","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1054\/plef.2001.0347","article-title":"The endocannabinoid system in invertebrates","volume":"66","author":"Salzet","year":"2002","unstructured":"161. Salzet M, Stefano GB. The endocannabinoid system in invertebrates. Prostaglandins Leukot Essent Fat Acids 2002;66:353-61.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1139\/y75-109","article-title":"The effects of delta9-tetrahydrocannabinol on action potentials in the mollusc Aplysia","volume":"53","author":"Acosta-Urquidi J","year":"1975","unstructured":"162. Acosta-Urquidi J, Chase R. The effects of delta9-tetrahydrocannabinol on action potentials in the mollusc Aplysia. Can J Physiol Pharmacol 1975;53:793-8.","journal-title":"Can J Physiol Pharmacol"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"163. Zimmerman AM, Zimmerman SB. The Influence of Marihuana on Eukaryote Cell Growth and Development. In: Nahas GG, Paton WDM, Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4 JE, eds. Marihuana. Berlin, Heidelberg: Springer; 1976:195-205.","DOI":"10.1007\/978-3-642-51624-5_17"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000136610","article-title":"Action of delta 9-tetrahydrocannabinol on cell division and macromolecular synthesis in division-synchronized protozoa","volume":"14","author":"DK","year":"1976","unstructured":"164. McClean DK, Zimmerman AM. Action of delta 9-tetrahydrocannabinol on cell division and macromolecular synthesis in division-synchronized protozoa. Pharmacology 1976;14:307-21.","journal-title":"Pharmacology"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1420-9101.2005.01028.x","article-title":"Cannabinoid receptors in invertebrates","volume":"19","author":"McPartland","year":"2006","unstructured":"165. McPartland JM, Agraval J, Gleeson D, Heasman K, Glass M. Cannabinoid receptors in invertebrates. J Evol Biol 2006;19:366-73.","journal-title":"J Evol Biol"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1073\/pnas.91.16.7678","article-title":"Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction","volume":"91","author":"Schuel","year":"1994","unstructured":"166. Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci U S A 1994;91:7678-82.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10695-013-9783-9","article-title":"Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs","volume":"39","author":"Cottone","year":"2013","unstructured":"167. Cottone E, Pomatto V, Cerri F, et al. Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs. Fish Physiol Biochem 2013;39:1287-96.","journal-title":"Fish Physiol Biochem"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0306-4522(98)00749-0","article-title":"Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response","volume":"92","author":"De Petrocellis","year":"1999","unstructured":"168. De Petrocellis L, Melck D, Bisogno T, Milone A, Di Marzo V. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 1999;92: 377-87.","journal-title":"Neuroscience"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/dgd.12351","article-title":"Role of the endocannabinoid system in vertebrates: emphasis on the zebrafish model","volume":"59","author":"Oltrabella","year":"2017","unstructured":"169. Oltrabella F, Melgoza A, Nguyen B, Guo S. Role of the endocannabinoid system in vertebrates: emphasis on the zebrafish model. Dev Growth Differ 2017;59:194-210.","journal-title":"Dev Growth Differ"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/10799893.2018.1494743","article-title":"Investigation of non-CB 1, non-CB 2 WIN55212-2-sensitive G-protein-coupled receptors in the brains of mammals, birds, and amphibians","volume":"38","author":"Breivogel","year":"2018","unstructured":"170. Breivogel CS, McPartland JM, Parekh B. Investigation of non-CB 1, non-CB 2 WIN55212-2-sensitive G-protein-coupled receptors in the brains of mammals, birds, and amphibians. J Recept Signal Transduct 2018;38:316-26.","journal-title":"J Recept Signal Transduct"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1046\/j.1432-1327.2000.01550.x","article-title":"Comparative biology of the endocannabinoid system possible role in the immune response","volume":"267","author":"Salzet","year":"2000","unstructured":"171. Salzet M, Breton C, Bisogno T, Di Marzo V. Comparative biology of the endocannabinoid system possible role in the immune response. Eur J Biochem 2000; 267:4917-27.","journal-title":"Eur J Biochem"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"172. Freundt-Revilla J, Kegler K, Baumg\u00e4rtner W, Tipold A. Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system. PLoS One 2017;12:e0181064.","DOI":"10.1371\/journal.pone.0181064"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2011.08.002","article-title":"Cloning and pharmacological characterization of the dog cannabinoid CB\u2082receptor","volume":"669","author":"Ndong","year":"2011","unstructured":"173. Ndong C, O'Donnell D, Ahmad S, Groblewski T. Cloning and pharmacological characterization of the dog cannabinoid CB\u2082receptor. Eur J Pharmacol 2011; 669:24-31.","journal-title":"Eur J Pharmacol"},{"key":"ref185","doi-asserted-by":"publisher","unstructured":"174. Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol 1999;276: H2085-93.","DOI":"10.1152\/ajpheart.1999.276.6.H2085"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41593-018-0205-2","article-title":"Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type","volume":"21","author":"Boldog","year":"2018","unstructured":"175. Boldog E, Bakken TE, Hodge RD, et al. Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type. Nat Neurosci 2018;21:1185-95.","journal-title":"Nat Neurosci"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.tcam.2013.03.004","article-title":"Marijuana poisoning","volume":"28","author":"Fitzgerald","year":"2013","unstructured":"176. Fitzgerald KT, Bronstein AC, Newquist KL. Marijuana poisoning. Top Companion Anim Med 2013;28:8-12.","journal-title":"Top Companion Anim Med"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/bph.14165","article-title":"Species-specific susceptibility to cannabis-induced convulsions","volume":"176","author":"Whalley","year":"2019","unstructured":"177. Whalley BJ, Lin H, Bell L, et al. Species-specific susceptibility to cannabis-induced convulsions. Br J Pharmacol 2019;176:1506-23.","journal-title":"Br J Pharmacol"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13028-018-0398-0","article-title":"Marijuana intoxication in a cat","volume":"60","author":"Janeczek","year":"2018","unstructured":"178. Janeczek A, Zawadzki M, Szpot P, Niedzwiedz A. Marijuana intoxication in a cat. Acta Vet Scand 2018; 60:44.","journal-title":"Acta Vet Scand"},{"key":"ref190","unstructured":"179. Donaldson CW. Marijuana exposure in animals. Vet Med 2002;97:437-41. Available at: https:\/\/www. researchgate.net\/publication\/289310520_Marijuana_exposure_in_animals (accessed November 18, 2019)."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.nhtm.2014.12.002","article-title":"Translational medicine definition by the European Society for Translational Medicine","volume":"2","author":"Cohrs","year":"2014","unstructured":"180. Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A. Translational medicine definition by the European Society for Translational Medicine. New Horiz Transl Med 2014;2:86.","journal-title":"New Horiz Transl Med"},{"key":"ref192","unstructured":"181. European Patients' Academy (EUPATI). Translational medicine. Published 2015. Available at: https:\/\/www.eupati.eu\/non-clinical-studies\/transla-tional-medicine\/ (accessed November 25, 2019)."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/jor.23828","article-title":"Canine hip dysplasia: a natural animal model for human developmental dysplasia of the hip","volume":"36","author":"Pascual-Garrido","year":"2018","unstructured":"182. Pascual-Garrido C, Guilak F, Rai MF, et al. Canine hip dysplasia: a natural animal model for human developmental dysplasia of the hip. J Orthop Res 2018;36:1807-17.","journal-title":"J Orthop Res"},{"key":"ref194","doi-asserted-by":"publisher","unstructured":"183. Oberbauer AM, Keller GG, Famula TR. Long-term genetic selection reduced prevalence of hip and elbow dysplasia in 60 dog breeds. PLoS One 2017;12: e0172918.","DOI":"10.1371\/journal.pone.0172918"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/jor.24432","article-title":"Dog as a model for osteoarthritis: the FGF4 retrogene insertion may matter","volume":"37","author":"Tellegen","year":"2019","unstructured":"184. Tellegen AR, Dessing AJ, Houben K, et al. Dog as a model for osteoarthritis: the FGF4 retrogene insertion may matter. J Orthop Res 2019;37:2550-60.","journal-title":"J Orthop Res"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1038\/s41598-018-23940-z","article-title":"Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care","volume":"8","author":"Anderson","year":"2018","unstructured":"185. Anderson KL, O'Neill DG, Brodbelt DC, et al. Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Sci Rep 2018;8:5641.","journal-title":"Sci Rep"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jor.24178","article-title":"Gene expression in hip soft tissues in incipient canine hip dysplasia and osteoarthritis","volume":"37","author":"Todhunter","year":"2019","unstructured":"186. Todhunter RJ, Garrison SJ, Jordan J, et al. Gene expression in hip soft tissues in incipient canine hip dysplasia and osteoarthritis. J Orthop Res 2019;37: 313-24.","journal-title":"J Orthop Res"},{"key":"ref198","doi-asserted-by":"publisher","unstructured":"187. Yassin M, Robinson D. Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. Int J Anesth Pain Med 2017,3:2.","DOI":"10.21767\/2471-982X.100016"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/sctm.18-0020","article-title":"Intra-articular administration of autologous micro-fragmented adipose tissue in dogs with spontaneous osteoarthritis: safety, feasibility, and clinical outcomes","volume":"7","author":"Zeira","year":"2018","unstructured":"188. Zeira O, Scaccia S, Pettinari L, et al. Intra-articular administration of autologous micro-fragmented adipose tissue in dogs with spontaneous osteoarthritis: safety, feasibility, and clinical outcomes. Stem Cells Transl Med 2018;7:819-28.","journal-title":"Stem Cells Transl Med"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000471786","article-title":"High-dose cannabidiol induced hypotension after global hypoxia-ischemia in piglets","volume":"112","author":"Garberg","year":"2017","unstructured":"189. Garberg HT, Solberg R, Barlinn J, Martinez-Orgado J, L\u00f8berg EM, Saugstad OD. High-dose cannabidiol induced hypotension after global hypoxia-ischemia in piglets. Neonatology 2017;112:143-9.","journal-title":"Neonatology"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fnins.2016.00323","article-title":"Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia","volume":"10","author":"Lafuente","year":"2016","unstructured":"190. Lafuente H, Pazos MR, Alvarez A, et al. Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia. Front Neurosci 2016;10:323.","journal-title":"Front Neurosci"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/pr.2017.104","article-title":"Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets","volume":"82","author":"Arruza","year":"2017","unstructured":"191. Arruza L, Pazos MR, Mohammed N, et al. Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets. Pediatr Res 2017; 82:79-86.","journal-title":"Pediatr Res"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11481-013-9445-9","article-title":"Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation","volume":"8","author":"Rom","year":"2013","unstructured":"192. Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol 2013;8:608-20.","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0165-2427(01)00357-9","article-title":"Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages","volume":"82","author":"Ponti","year":"2001","unstructured":"193. Ponti W, Rubino T, Bardotti M, Poli G, Parolaro D. Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages. Vet Immunol Immunopathol 2001;82:203-14.","journal-title":"Vet Immunol Immunopathol"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/vetsci2030111","article-title":"Cats, cancer and comparative oncology","volume":"2","author":"Cannon","year":"2015","unstructured":"194. Cannon CM. Cats, cancer and comparative oncology. Vet Sci 2015;2:111-26.","journal-title":"Vet Sci"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1089\/aid.1990.6.1373","article-title":"Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function","volume":"6","author":"Siebelink","year":"1990","unstructured":"195. Siebelink KH, Chu IH, Rimmelzwaan GF, et al. Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res Hum Retroviruses 1990;6:1373-8.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/157016210790416389","article-title":"Feline immunodeficiency virus (FIV) as a model for study of Lentivirus infections: parallels with HIV","volume":"8","author":"Elder","year":"2010","unstructured":"196. Elder JH, Lin YC, Fink E, Grant CX. Feline immunodeficiency virus (FIV) as a model for study of Lentivirus infections: parallels with HIV. Curr HIV Res 2010;8:73-80.","journal-title":"Curr HIV Res"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1570162033352101","article-title":"Transmission and immunopathogenesis of FIV in cats as a model for HIV","volume":"1","author":"Burkhard","year":"2003","unstructured":"197. Burkhard M, Dean G. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 2003;1:15-29.","journal-title":"Curr HIV Res"},{"key":"ref209","doi-asserted-by":"publisher","unstructured":"198. Jergens AE, Simpson KW. Inflammatory bowel disease in veterinary medicine. Front Biosci (Elite Ed) 2012;4:1404-19.","DOI":"10.2741\/e470"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/vr.d5380","article-title":"Canine breeds at high risk of developing inflammatory bowel disease in the south-eastern UK","volume":"169","author":"Kathrani","year":"2011","unstructured":"199. Kathrani A, Werling D, Allenspach K. Canine breeds at high risk of developing inflammatory bowel disease in the south-eastern UK. Vet Rec 2011;169:635.","journal-title":"Vet Rec"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1939-1676.2007.tb03011.x","article-title":"Chronic enteropathies in dogs: evaluation of risk factors for negative outcome","volume":"21","author":"Allenspach","year":"2007","unstructured":"200. Allenspach K, Wieland B, Gr\u00f6ne A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007;21:700-8.","journal-title":"J Vet Intern Med"},{"key":"ref212","doi-asserted-by":"publisher","unstructured":"201. Kathrani A, House A, Catchpole B, et al. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs. PLoS One 2010;5:e15740.","DOI":"10.1371\/journal.pone.0015740"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1038\/nmicrobiol.2016.177","article-title":"Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks","volume":"1","author":"V\u00e1zquez-Baeza","year":"2016","unstructured":"202. V\u00e1zquez-Baeza Y, Hyde ER, Suchodolski JS, Knight R. Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks. Nat Microbiol 2016;1:16177.","journal-title":"Nat Microbiol"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3748\/wjg.v16.i9.1050","article-title":"Inflammatory bowel disease in the dog: differences and similarities with humans","volume":"16","author":"Cerquetella","year":"2010","unstructured":"203. Cerquetella M, Spaterna A, Laus F, et al. Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterol 2010;16: 1050-6.","journal-title":"World J Gastroenterol"},{"key":"ref215","doi-asserted-by":"publisher","unstructured":"204. Littman MP, Dambach DM, Vaden SL, Giger U. Familial protein-losing enteropathy and protein-losing nephropathy in soft coated wheaten terriers: 222 cases (1983-1997). J Vet Intern Med 2000;14:68-80.","DOI":"10.1111\/j.1939-1676.2000.tb01502.x"},{"key":"ref216","unstructured":"205. United State Department of Agriculture. Animal and Plant Health Inspection Services (USDA:APHIS). Incidence of colic in U.S. horses. October 2001. Available at: https:\/\/www.aphis.usda.gov\/animal_health\/nahms\/equine\/downloads\/equine98\/Equine98_is_Colic.pdf (accessed January 10,2020)."},{"key":"ref217","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1939-1676.2000.tb01164.x","article-title":"Chronic idiopathic inflammatory bowel diseases of the horse","volume":"14","author":"Schumacher","year":"2000","unstructured":"206. Schumacher J, Edwards JF, Cohen ND. Chronic idiopathic inflammatory bowel diseases of the horse. J Vet Intern Med 2000;14:258-65.","journal-title":"J Vet Intern Med"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12917-018-1343-1","article-title":"Inflammatory bowel disease (IBD) in horses: a retrospective study exploring the value of different diagnostic approaches","volume":"14","author":"Boshuizen","year":"2018","unstructured":"207. Boshuizen B, Ploeg M, Dewulf J, et al. Inflammatory bowel disease (IBD) in horses: a retrospective study exploring the value of different diagnostic approaches. BMC Vet Res 2018;14:21.","journal-title":"BMC Vet Res"},{"key":"ref219","doi-asserted-by":"publisher","unstructured":"208. Gough A, Thomas A, O'Neill D. Breed Predispositions to Disease in Dogs and Cats. Chichester, UK: John Wiley & Sons, Ltd; 2018.","DOI":"10.1002\/9781119225584"},{"key":"ref220","unstructured":"209. Mandigers P, German AJ. Dietary hypersensitivity in cats and dogs. Tijdschr Diergeneeskd 2010;135:706-10."},{"key":"ref221","doi-asserted-by":"publisher","unstructured":"210. Dandrieux JRS. Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same? J Small Anim Pract 2016;57:589-99.","DOI":"10.1111\/jsap.12588"},{"key":"ref222","unstructured":"211. Kent A. Canine chronic enteropathy. Vet Times 2017:47. Available at:"},{"key":"ref223","unstructured":"https:\/\/www.vettimes.co.uk\/app\/uploads\/wp-post-to-pdf-enhanced-cache\/1\/canine-chronic-enteropathy.pdf (accessed January 10, 2020)."},{"key":"ref224","unstructured":"212. Willard MD. Digestive System Disorders. In: Nelson RW, Richard RW, Couto CG, eds. Small Animal Internal Medicine. 4th ed. St. Louis, MO: Mosby Elsevier; 2009:440-75."},{"key":"ref225","unstructured":"213. Defarges A. Inflammatory Bowel Disease in Small Animals. In: MSD Manual: Veterinary Manual. Kenilworth, NJ: Merck & Co., Inc.: 2020. Available at: https:\/\/www.msdvetmanual.com\/digestive-system\/diseases-of-the-stomach-and-intestines-in-small-animals\/inflammatory-bowel-disease-in-small-animals (accessed November 24, 2019)."},{"key":"ref226","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/jvim.15571","article-title":"Diagnostic features, treatment, and outcome of dogs with inflammatory protein-losing enteropathy","volume":"33","author":"Salavati Schmitz","year":"2019","unstructured":"214. Salavati Schmitz S, Gow A, Bommer N, Morrison L, Mellanby R. Diagnostic features, treatment, and outcome of dogs with inflammatory protein-losing enteropathy. J Vet Intern Med 2019;33:2005-13.","journal-title":"J Vet Intern Med"},{"key":"ref227","unstructured":"215. Allenspach K. Pathogenesis of IBD in Dogs. In: Proceedings of the Southern European Veterinary Conference and Congreso Nacional AVEPA. Published in IVIS with the permission of SEVC & AVEPA; 2016. www.ivis.org (accessed November 24, 2019)."},{"key":"ref228","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/0300985811404712","article-title":"Feline gastrointestinal lymphoma","volume":"49","author":"Moore","year":"2012","unstructured":"216. Moore PF, Rodriguez-Bertos A, Kass PH. Feline gastrointestinal lymphoma. Vet Pathol 2012;49:658-68.","journal-title":"Vet Pathol"},{"key":"ref229","doi-asserted-by":"publisher","unstructured":"217. Louwerens M, London CA, Pedersen NC, Lyons LA. Feline lymphoma in the post-feline leukemia virus era. J Vet Intern Med 2005;19:329-35.","DOI":"10.1111\/j.1939-1676.2005.tb02703.x"},{"key":"ref230","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5326\/JAAHA-MS-5554","article-title":"Recent trends in feline intestinal neoplasia: an epidemiologic study of 1,129 cases in the veterinary medical database from 1964 to 2004","volume":"47","author":"Rissetto","year":"2011","unstructured":"218. Rissetto K, Villamil JA, Selting KA, Tyler J, Henry CJ. Recent trends in feline intestinal neoplasia: an epidemiologic study of 1,129 cases in the veterinary medical database from 1964 to 2004. J Am Anim Hosp Assoc 2011;47:28-36.","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref231","doi-asserted-by":"publisher","unstructured":"219. Collette SA, Allstadt SD, Chon EM, et al. Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012). Vet Comp Oncol 2016; 14(Suppl 1):136-46.","DOI":"10.1111\/vco.12158"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5326\/JAAHA-MS-5807","article-title":"A review of 18 cases of feline colonic adenocarcinoma treated with subtotal colectomies and adjuvant carboplatin","volume":"48","author":"Arteaga","year":"2012","unstructured":"220. Arteaga TA, McKnight J, Bergman PJ. A review of 18 cases of feline colonic adenocarcinoma treated with subtotal colectomies and adjuvant carboplatin. J Am Anim Hosp Assoc 2012;48:399-404.","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2460\/javma.1997.211.07.878","article-title":"Malignant colonic neoplasia in cats: 46 cases (1990-1996)","volume":"211","author":"Slawienski","year":"1997","unstructured":"221. Slawienski MJ, Mauldin GE, Mauldin GN, Patnaik AK. Malignant colonic neoplasia in cats: 46 cases (1990-1996). J Am Vet Med Assoc 1997;211:878-81.","journal-title":"J Am Vet Med Assoc"},{"key":"ref234","doi-asserted-by":"publisher","unstructured":"222. Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci 2018;19: E833.","DOI":"10.3390\/ijms19030833"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/1009\/0\/PublishFiles\/1009Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:22:19Z","timestamp":1738750939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/44\/articles\/1009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":235,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10388","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}